Sangamo BioSciences | SGMO - القيمة السوقية





القيمة السوقية تغيير تاريخ
Alaunos Therapeutics USD 53M 48M 2026-03
Alnylam Pharmaceuticals USD 52.54B 7.24B 2025-12
Alterity Therapeutics Limited AUD 11M 5M 2023-06
Amgen USD 176.25B 24.32B 2025-12
Bayer EUR 38.45B 2.09B 2026-03
BioCryst Pharmaceuticals USD 1.7B 40M 2026-03
Biogen USD 25.82B 5.28B 2025-12
BioMarin Pharmaceutical USD 11.76B 348M 2026-03
Cipla INR 1.22T 6.47B 2025-12
Clal Biotechnology ILS 43.45M 8.92M 2026-03
Compugen USD 620.58M 475.91M 2026-03
CSL USD 71.32B 15.44B 2026-03
Gilead Sciences USD 152.28B 14.55B 2025-12
GlaxoSmithKline GBP 74.36B 10.31B 2025-12
Grifols EUR 2.02B 4.34B 2026-03
Ionis Pharmaceuticals USD 12.81B 2.39B 2025-12
J&J USD 500.24B 67.44B 2025-12
Merck USD 261.26B 51.62B 2025-12
Novartis USD 240.48B 51.73B 2026-03
Pfizer USD 153.96B 12.4B 2026-03
Roche Holding CHF 266.34B 55.46B 2025-12
Sanofi EUR 100.88B 4.46B 2025-12
Sarepta Therapeutics USD 2.26B 238M 2025-12
Tectonic Therapeutic USD 474M 84M 2026-03
Ultragenyx Pharmaceutical USD 2.22B 680M 2025-12
Vertex Pharmaceuticals USD 115.03B 14.61B 2025-12